{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T06:12:39Z","timestamp":1790230359783,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T00:00:00Z","timestamp":1720569600000},"content-version":"am","delay-in-days":313,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.thromres.2023.07.001","type":"journal-article","created":{"date-parts":[[2023,7,6]],"date-time":"2023-07-06T11:56:39Z","timestamp":1688644599000},"page":"107-113","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Antiplatelet and anticoagulant therapies in hereditary hemorrhagic telangiectasia: A large French cohort study (RETROPLACOTEL)"],"prefix":"10.1016","volume":"229","author":[{"given":"Vincent","family":"Grobost","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sami","family":"Hammi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Guilhem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Duffau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Seguier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Parrot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Gautier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Alric","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mallorie","family":"Kerjouan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Le Guillou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delphine","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Chaussavoine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murielle","family":"Rondeau-Lutz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Leguy-Seguin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Delagrange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Lavigne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Maillard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Dupuis-Girod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.thromres.2023.07.001_bb0005","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/gim.2013.66","article-title":"The use of US health insurance data for surveillance of rare disorders: hereditary hemorrhagic telangiectasia","volume":"16","author":"Grosse","year":"2014","journal-title":"Genet. Med."},{"issue":"2","key":"10.1016\/j.thromres.2023.07.001_bb0010","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1136\/thoraxjnl-2013-203720","article-title":"The UK prevalence of hereditary haemorrhagic telangiectasia and its association with sex, socioeconomic status and region of residence: a population-based study","volume":"69","author":"Donaldson","year":"2014","journal-title":"Thorax"},{"issue":"1","key":"10.1016\/j.thromres.2023.07.001_bb0015","first-page":"3","article-title":"Epidemiological investigation of Rendu-Osler disease in France: its geographical distribution and prevalence","volume":"44","author":"Bideau","year":"1989","journal-title":"Popul."},{"issue":"14","key":"10.1016\/j.thromres.2023.07.001_bb0020","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1056\/NEJM199510053331407","article-title":"Hereditary hemorrhagic telangiectasia","volume":"333","author":"Guttmacher","year":"1995","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.thromres.2023.07.001_bb0025","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1182\/blood.2020008739","article-title":"Hereditary hemorrhagic telangiectasia: systemic therapies, guidelines, and an evolving standard of care","volume":"137","author":"Al-Samkari","year":"2021","journal-title":"Blood."},{"issue":"4","key":"10.1016\/j.thromres.2023.07.001_bb0030","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.gie.2009.11.004","article-title":"High diagnostic and clinical impact of small-bowel capsule endoscopy in patients with hereditary hemorrhagic telangiectasia with overt digestive bleeding and\/or severe anemia","volume":"71","author":"Gr\u00e8ve","year":"2010","journal-title":"Gastrointest. Endosc."},{"issue":"1","key":"10.1016\/j.thromres.2023.07.001_bb0035","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/gim.2013.62","article-title":"Endoscopic evaluation of gastrointestinal tract in patients with hereditary hemorrhagic telangiectasia and correlation with their genotypes","volume":"16","author":"Canzonieri","year":"2014","journal-title":"Genet. Med."},{"issue":"2","key":"10.1016\/j.thromres.2023.07.001_bb0040","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1572-0241.2000.01792.x","article-title":"Gastrointestinal bleeding in patients with hereditary hemorrhagic telangiectasia","volume":"95","author":"Kjeldsen","year":"2000","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.thromres.2023.07.001_bb0045","first-page":"4798425","article-title":"Impact of age on outcomes in hospitalized patients with hereditary hemorrhagic telangiectasia","volume":"2018","author":"Iyer","year":"2018","journal-title":"Adv. Hematol."},{"issue":"5","key":"10.1016\/j.thromres.2023.07.001_bb0050","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.otohns.2006.12.019","article-title":"Health-related quality of life in hereditary hemorrhagic telangiectasia","volume":"136","author":"Geisthoff","year":"2007","journal-title":"Otolaryngol. Head Neck Surg."},{"issue":"9","key":"10.1016\/j.thromres.2023.07.001_bb0055","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1513\/AnnalsATS.201603-200OC","article-title":"High rates of bleeding complications among hospitalized patients with hereditary hemorrhagic telangiectasia in the United States","volume":"13","author":"Brinjikji","year":"2016","journal-title":"Ann, Am, Thorac, Soc."},{"issue":"1","key":"10.1016\/j.thromres.2023.07.001_bb0060","doi-asserted-by":"crossref","first-page":"E82","DOI":"10.3390\/jcm9010082","article-title":"Gastrointestinal bleeding in patients with hereditary hemorrhagic telangiectasia: risk factors and endoscopic findings","volume":"9","author":"Mora-Luj\u00e1n","year":"2019","journal-title":"J. Clin. Med."},{"issue":"18","key":"10.1016\/j.thromres.2023.07.001_bb0065","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1212\/WNL.0000000000001538","article-title":"Complications and mortality in hereditary hemorrhagic telangiectasia: a population-based study","volume":"84","author":"Donaldson","year":"2015","journal-title":"Neurology."},{"key":"10.1016\/j.thromres.2023.07.001_bb0070","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s13023-016-0427-x","article-title":"Life expectancy of parents with hereditary haemorrhagic telangiectasia","volume":"11","author":"de Gussem","year":"2016","journal-title":"Orphanet. J. Rare Dis."},{"issue":"1","key":"10.1016\/j.thromres.2023.07.001_bb0075","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s13023-016-0533-9","article-title":"20-year follow-up study of Danish HHT patients\u2013survival and causes of death","volume":"11","author":"Kjeldsen","year":"2016","journal-title":"Orphanet .J. Rare Dis."},{"issue":"1","key":"10.1016\/j.thromres.2023.07.001_bb0080","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13023-020-01579-2","article-title":"Predictors of mortality in patients with hereditary hemorrhagic telangiectasia","volume":"16","author":"Thompson","year":"2021","journal-title":"Orphanet .J. Rare Dis."},{"issue":"4","key":"10.1016\/j.thromres.2023.07.001_bb0085","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1136\/thoraxjnl-2011-201076","article-title":"Low serum iron levels are associated with elevated plasma levels of coagulation factor VIII and pulmonary emboli\/deep venous thromboses in replicate cohorts of patients with hereditary haemorrhagic telangiectasia","volume":"67","author":"Livesey","year":"2012","journal-title":"Thorax"},{"issue":"5","key":"10.1016\/j.thromres.2023.07.001_bb0090","first-page":"1031","article-title":"Elevated factor VIII in hereditary haemorrhagic telangiectasia (HHT): association with venous thromboembolism","volume":"98","author":"Shovlin","year":"2007","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2023.07.001_bb0095","article-title":"Natural history of patients with venous thromboembolism and hereditary hemorrhagic telangiectasia. Findings from the RIETE registry","volume":"14(1):196","author":"Riera-Mestre","year":"2019","journal-title":"Orphanet .J. Rare Dis."},{"issue":"9","key":"10.1016\/j.thromres.2023.07.001_bb0100","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1056\/NEJMc1213554","article-title":"Antiplatelet and anticoagulant agents in hereditary hemorrhagic telangiectasia","volume":"368","author":"Devlin","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.thromres.2023.07.001_bb0105","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1007\/s00277-012-1553-8","article-title":"Hereditary hemorrhagic telangiectasia patients can tolerate anticoagulation","volume":"91","author":"Edwards","year":"2012","journal-title":"Ann. Hematol."},{"issue":"1","key":"10.1016\/j.thromres.2023.07.001_bb0110","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13023-019-1179-1","article-title":"Safety of direct oral anticoagulants in patients with hereditary hemorrhagic telangiectasia","volume":"14","author":"Shovlin","year":"2019","journal-title":"Orphanet .J. Rare Dis."},{"issue":"1","key":"10.1016\/j.thromres.2023.07.001_bb0115","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1186\/s13023-019-1278-z","article-title":"Safety of antithrombotic therapy in subjects with hereditary hemorrhagic telangiectasia: prospective data from a multidisciplinary working group","volume":"14","author":"Gaetani","year":"2019","journal-title":"Orphanet .J. Rare Dis."},{"issue":"12","key":"10.1016\/j.thromres.2023.07.001_bb0120","doi-asserted-by":"crossref","first-page":"989","DOI":"10.7326\/M20-1443","article-title":"Second international guidelines for the diagnosis and management of hereditary hemorrhagic telangiectasia","volume":"173","author":"Faughnan","year":"2020","journal-title":"Ann. Intern. Med."},{"issue":"1","key":"10.1016\/j.thromres.2023.07.001_bb0125","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/(SICI)1096-8628(20000306)91:1<66::AID-AJMG12>3.0.CO;2-P","article-title":"Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome)","volume":"91","author":"Shovlin","year":"2000","journal-title":"Am. J. Med. Genet."},{"issue":"4","key":"10.1016\/j.thromres.2023.07.001_bb0130","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","article-title":"Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients","volume":"3","author":"Schulman","year":"2005","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2023.07.001_bb0135","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.thromres.2020.10.019","article-title":"Bleeding events during anticoagulation in patients with hereditary hemorrhagic telangiectasia","volume":"197","author":"Tentoni","year":"2021","journal-title":"Thromb. Res."},{"issue":"6","key":"10.1016\/j.thromres.2023.07.001_bb0140","doi-asserted-by":"crossref","first-page":"E1699","DOI":"10.3390\/jcm9061699","article-title":"Antithrombotic therapy in hereditary hemorrhagic telangiectasia: real-world Data from the Gemelli Hospital HHT registry","volume":"9","author":"Gaetani","year":"2020","journal-title":"J. Clin. Med."},{"issue":"7","key":"10.1016\/j.thromres.2023.07.001_bb0145","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1056\/NEJMoa1711948","article-title":"Edoxaban for the treatment of cancer-associated venous thromboembolism","volume":"378","author":"Raskob","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"20","key":"10.1016\/j.thromres.2023.07.001_bb0150","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1200\/JCO.2018.78.8034","article-title":"Comparison of an oral factor Xa inhibitor with low molecular weight heparin in patients with cancer with venous thromboembolism: results of a randomized trial (SELECT-D)","volume":"36","author":"Young","year":"2018","journal-title":"J. Clin. Oncol."},{"issue":"8","key":"10.1016\/j.thromres.2023.07.001_bb0155","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1055\/s-0038-1667001","article-title":"Clinical impact of bleeding in cancer-associated venous thromboembolism: results from the Hokusai VTE Cancer Study","volume":"118","author":"Kraaijpoel","year":"2018","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2023.07.001_bb0160","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.thromres.2021.10.022","article-title":"Risk factors and one-year mortality in patients with direct oral anticoagulant-associated gastrointestinal bleeding","volume":"208","author":"Verso","year":"2021","journal-title":"Thromb. Res."},{"issue":"11","key":"10.1016\/j.thromres.2023.07.001_bb0165","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1016\/j.cgh.2017.04.031","article-title":"Risk of gastrointestinal bleeding in patients taking non-vitamin K antagonist oral anticoagulants: a systematic review and meta-analysis","volume":"15","author":"Miller","year":"2017","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"9921","key":"10.1016\/j.thromres.2023.07.001_bb0170","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","article-title":"Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials","volume":"383","author":"Ruff","year":"2014","journal-title":"Lancet."},{"key":"10.1016\/j.thromres.2023.07.001_bb0175","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.thromres.2020.11.014","article-title":"Heavy menstrual bleeding in women on oral anticoagulants","volume":"197","author":"Samuelson Bannow","year":"2021","journal-title":"Thromb. Res."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004938482300213X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004938482300213X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:51:24Z","timestamp":1758736284000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004938482300213X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":35,"alternative-id":["S004938482300213X"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2023.07.001","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antiplatelet and anticoagulant therapies in hereditary hemorrhagic telangiectasia: A large French cohort study (RETROPLACOTEL)","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2023.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}